TGF-β1 expression and chronic allograft nephropathy in protocol kidney graft biopsy

Physiological Research

Volumn 52, Issue 3, 2003, Pages 353-360

  Viklicky O ^a   Matl, Ivo ^a   Voska, L ^a   Bohmova R ^a   Jaresova M ^a   Lacha J ^a   Lodererova A ^a   Striz I ^a   Teplan, V ^a   Vitko S ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Biopsy; Chronic rejection; Fibrogenesis; Kidney transplantation

Indexed keywords

CYCLOSPORIN; CYTOKINE; LIPID; TRANSFORMING GROWTH FACTOR BETA1; CREATINE; IMMUNOSUPPRESSIVE AGENT; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC DISEASE; CLINICAL ARTICLE; CREATININE CLEARANCE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; LIPID BLOOD LEVEL; MALE; PATHOGENESIS; POSTOPERATIVE PERIOD; PROTEINURIA; VASCULAR DISEASE; ANALYSIS OF VARIANCE; BLOOD; CHEMISTRY; DRUG EFFECT; GLOMERULUS; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BODY MASS INDEX; CREATINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 10744230732     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AWAD MR, EL-GAMEL A, HASLETON P, TURNER DM, SINNOTT PJ, HUTCHINSON IV: Genotypic variation in the transforming growth factor-β1 gene. Transplantation 66: 1014-1020, 1998.
2. BORDER WA, NOBLE NA: TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 51: 1388-1396, 1997.
3. COCKROFT DN, GAULT MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 1631-1641, 1976.
4. 1 in renal allograft recipients. Transplantation 57: 1727-1731, 1994.
5. CUHACI B, KUMAR MSA, BLOOM RD, PRATT B, HAUSSMAN G, LASKOW DA, ALIDOOST M, GROTKOWSKI C, CAHILL K, BUTANI L, STURGILL BC, PANKEWYCZ OG: Transforming growth factor-β levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 68: 785-790, 1999.
6. FELLSTRÖM B: Nonimmune risk factors for chronic renal allograft dysfunction. Transplantation 71: SS10-SS16, 2001.
7. FURNESS PN: Histopathology of chronic renal allograft dysfunction. Transplantation 71: SS31-SS36, 2001.
8. HORVATH LZ, FRIESS H, SCHILLING M, BORISH B, DEFLORIN J, GOLD LI, KORC M, BUCHLER MW: Altered expression of transforming growth factor-β in chronic renal rejection. Kidney Int 50: 489-498, 1996
9. KHANNA A, KAPUR S, SHARMA V, LI B, SUTHATHIRAN M. In vivo hyperexpression of transforming growth factor β1 in mice: stimulation by cyclosporine. Transplantation 63: 1037-1039, 1997.
10. LEGENDRE C, THERVET E, SKHIRI H, MAMZER-BRUNEEL M-F, CANTAROVICH F, NOËL L-H, KREIS H: Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 65: 1506-1509, 1998.
11. LEHTONEN SRK, TASKINEN EI, ISONIEMI HM: Histological alterations in implant and one-year protocol biopsy specimens of renal allografts. Transplantation 72: 1138-1144, 2001.
12. MEIER-KRIESCHE H-U, ARNDORFER JA, KAPLAN B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73: 70-74, 2002.
13. MOHAMED MAS, ROBERTSON H, BOOTH TA, BALUPURI S, KIRBY JA, TALBOT D. TGF-β expression in renal transplant biopsies. Transplantation 69: 1002-1005, 2000.
14. NANKIVELL BJ, FENTON-LEE CA, KUYPERS DRJ, CHEUNG E, ALLEN RDM, O'CONNELL PJ, CHAPMAN JR: Effect of histological damage on long-term kidney transplant outcome. Transplantation 71: 515-523, 2001.
15. PAUL LC, DE FIJTER JW, SIJPKENS YWJ: Chronic renal transplant rejection. In: Kidney Transplantation. PJ MORRIS (ed), WB Saunders, Philadelphia, 2001, pp 408-418.
16. PAUL LC: Immunologic risk factors for chronic renal allograft dysfunction. Transplantation 71: SS17-SS23, 2001.
17. RACUSEN LC, SOLEZ K, COLVIN RB, BONSIB SM, CASTRO MC, CAVALLO T, CROKER BP, DEMETRIS J, DRACHENBERG CB, FOGO AB, FURNESS P, GABER LW, GIBSON IW, GLOTZ D, GOLDBERG JC, GRANDE J, HALLORAN PF, HANSEN HE, HARTLEY B, HAYRY PJ, HILL CM, HOFFMAN EO, HUNSICKER LG, LINDBLAD AS, MARCUSSEN N, MIHATSCH MJ, NADASDY T, NICKERSON P, OLSEN TS, PAPADIMITRIOU JC, RANDHAWA PS, RAYNER DC, ROBERTS I, ROSE S, RUSH D, SALINAS-MADRIGAL L, SALOMON DR, SUND S, TASKINEN E, TRPKOV K, YAMAGUCHI Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999.
18. RUSH D, NICKERSON P, JEFFERY J: Protocol biopsies in the management of renal allograft recipients. Curr Opin Nephrol Hypertens 9: 615-619, 2000.
19. RUSH DN, NICKERSON P, JEFFERY JR, MCKENNA RM, GRIMM PC, GOUGH J: Protocol biopsies in renal transplantation: research tool or clinically useful? Curr Opin Nephrol Hypertens 7: 691-694, 1998.
20. SERON D, MORESO F, RAMÓN JM, HUESO M, CONDOM E, FULLADOSA X, BOVER J, GILVERNET S, CASTELAO AM, ALSINA J, GRINYÓ JM: Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 69: 1849-1855, 2000.
21. 1 centered fibrogenic cytokine paradigm for disease progression. Graft 1 (Suppl II): 25-28, 1998.
22. SOLEZ K, VINCENTI F, FILO RS: Histopathologic findings from 2-year protocol biopsies from U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 kidney transplant study group. Transplantation 66: 1736-1740, 1998.
23. WALTENBERG J, MIYAZONO K, FUNA K, WANDERS A, FELLSTRÖM B, HELDIN C-H: Transforming growth factor-β and organ transplantation. Transplant Proc 25: 2038-2040, 1993.